As a leading Angel Group we have helped 160+ companies launch

We are a Tucson, Arizona based non-profit organization of accredited investors who seek opportunities to invest in Southwest regional and U.S. national startup or early stage companies.

Welcome to 2023 a time when angel investing is heating up!
click now to learn more about becoming a member!


angel investors




portfolio companies

Present your Company

The DESERT ANGELS ™ welcomes applications from startup or early stage companies. We evaluate applications on an ongoing basis and meet monthly from September through June.

Present your company
Created with Sketch.


If you are an accredited investor with an appetite for helping early-stage companies succeed, we welcome you to join us.

Join now
Created with Sketch.
January 22, 2018

It is safe to say that there would have been no Calimmune without the early support of the Desert Angels.

Many members of the DA share our passion and see the potential for gene therapy to transform healthcare and liberate patients from chronic and incurable diseases. Their investments have helped us grow this company to what it is today. We truly hope Calimmune’s work will be life-changing for the people we plan to serve and the investors that supported us.

Calimmune has assembled a world-class team of researchers, clinicians and translational experts in related fields of science and medicine to develop innovative cell-based therapies for HIV.

Latest News and Updates

February’s FORGE Fireside is Marcia Dawood, advisor to the U.S. Securities and Exchange Commission’s Small Business Capital Formation Committee, venture partner with Mindshift Capital, managing director of Golden Seeds, host of the Angel Next Door Podcast, and Chair Emeritus of the Angel Capital Association (ACA), the global professional society for angel investors. Among many other topics, we discuss the psychology of money […]

Keep reading

Tucson has many programs and sources available to technology startups to provide resources and a better chance of success. According to the United States Census Bureau, around 600,000 small businesses have been started in the U.S. each year since 2015. Out of these businesses, 53.6% will fail before they hit their five-year mark, and 75.3% […]

Keep reading

Reglagene, Inc., a pioneering therapeutics company at the forefront of developing breakthrough therapies for brain diseases utilizing small molecule medicines that cross the blood-brain barrier to treat high grade gliomas and other cancers, announced that it has closed its non-brokered private placement of convertible preferred stock.  The offering, which was oversubscribed, resulted in aggregate gross […]

Keep reading